Cardiff Oncology, Inc. (CRDF)
CIK 1213037 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cardiff Oncology, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 26, 2026 | DEFA14A | 0001193125-26-368287 |
| Aug 26, 2026 | DEF 14A | 0001193125-26-368249 |
| Aug 14, 2026 | PRE 14A | 0001193125-26-352135 |
| Aug 11, 2026 | 10-Q | 0001193125-26-344545 |
| Aug 11, 2026 | 8-K | 0001193125-26-344645 |
| Jul 27, 2026 | SCHEDULE 13G/A | 0002012383-26-002222 |
| Jul 21, 2026 | S-8 | 0001193125-26-310273 |
| Jul 16, 2026 | 4 | 0001193125-26-306072 |
| Jul 16, 2026 | 4 | 0001193125-26-306083 |
| Jul 16, 2026 | 424B5 | 0001193125-26-305465 |
| Jul 16, 2026 | 8-K | 0001193125-26-305467 |
| Jun 22, 2026 | 4 | 0001184778-26-000009 |
| Jun 22, 2026 | 4 | 0001664708-26-000002 |
| Jun 15, 2026 | 4 | 0001184778-26-000007 |
| Jun 15, 2026 | 4 | 0001635493-26-000002 |
| Jun 15, 2026 | 4 | 0001393415-26-000002 |
| Jun 15, 2026 | 4 | 0001370087-26-000005 |
| Jun 15, 2026 | 4 | 0001543174-26-000005 |
| Jun 11, 2026 | 8-K | 0001193125-26-267563 |
| Jun 3, 2026 | 8-K | 0001193125-26-254658 |
| May 29, 2026 | 8-K | 0001193125-26-248711 |
| May 19, 2026 | 8-K | 0001193125-26-231040 |
| May 14, 2026 | 10-Q | 0001213037-26-000011 |
| May 14, 2026 | 8-K | 0001213037-26-000013 |
| Apr 28, 2026 | 3 | 0002132312-26-000003 |